Lineagen grabs $3.5 mln in Series C financing
Lineagen has raised $3.5 million in Series C financing. Signal Peak Ventures and Sanderling Ventures led the round with participation from PrairieGold Venture Partners, Mesa Verde Venture Partners, Archipel Capital, University Venture Fund, Hatteras Funds and KickStart Seed Fund. Based in Salt Lake City, Lineagen is a molecular diagnostics company focused on genetic disorders.
18 December 2013•4 mins read
